Insiders · Profile

Ultragenyx Pharmaceutical Inc.

Director at Arcturus Therapeutics. Filing since 8 Dec 2020. CIK 0001515673

Company
Date
Role
Action
Shares
Amount
Of holding
11 Aug 2021
Director
Sold, plan not stated
75,000
$3.44M
5.1%
10 Aug 2021
Director
Sold, plan not stated
725,000
$40.19M
33.0%
9 Dec 2020
Director
Sold, plan not stated
357,745
$33.98M
14.0%
8 Dec 2020
Director
Sold, plan not stated
442,255
$46.68M
14.7%
4 decisions on file.